Neuromodulation

Neuromodulation Device Design and Development

An ISO 13485-certified partner for neuromodulation and neurotech devices, from initial concept through to production.

Cambridge Design Partnership (CDP) is a medical device design and development consultancy for neuromodulation and neurotech companies. We develop implantable neurostimulation systems, implant delivery systems and external devices, for therapies such as spinal cord stimulation. Whether we start with your initial concept or join at a later stage of development, we work flexibly with your team to make sure your innovation is feasible, usable, commercially viable, compliant, manufacturable and wanted by users.

Our collaborative expert team can address a wide variety of your needs such as to:

• Gain further insights on user and stakeholder needs to refine your innovation
• Develop and test technical solutions for implantable devices, delivery systems, or external devices
• Design engaging, usable solutions for patients and clinicians
• Conduct formative and summative human factors (usability) studies
• Transform proof-of-concept prototypes into production solutions
• Build digital and data science strategies

Navigating Neuromodulation Innovation Trends

Neuromodulation is changing fast. Companies are pursuing less invasive implant procedures, longer-lasting power through efficient through-body charging, MRI conditionality, closed-loop therapies driven by data analytics, new stimulation waveforms, and companion apps that help patients stay engaged with their therapy. Each trend brings technical, usability, regulatory and commercial challenges.

CDP applies innovation methods built for these challenges and tailors the approach to your therapy and commercial goals.

Neurotech Trends